in focus
Percentage of donor organs recovered for transplant in the U.S. with machine perfusion intended or performed by donation quarter and organ
Quarters from April 1, 2015 to December 31, 2018. Based on data from the national Organ Procurement and Transplantation Network (OPTN).
Lung perfusion has more than tripled since 2015, growing from 1.7 percent to 6.3 percent and potentially expanding the pool of organs available for transplant.
The proportion of livers being treated with this transformative technology (including normothermic, hypothermic and other perfusion), also showed similar steady growth, jumping from just .1 percent in 2016 to 1.4 percent by the end of 2018. The OPTN began collecting data (from the Deceased Donor Registration) on the percentage of donor organs intended for ex vivo normothermic machine perfusion (NMP) and their location four years ago.
Read about the potential impact of NMP on transplantation and meet the companies leading the way in its development.
in focus
Number of donor organs (heart, liver, and lung) recovered for transplant in the U.S. with machine perfusion intended or performed
Based on data from the national Organ Procurement and Transplantation Network (OPTN).
In focus
HOPE Act impact continues at five-year milestone
More than 220 transplants have been performed to date through the HOPE Act.
LifeShare of Oklahoma increases DCD donor recovery during COVID-19
DCD recoveries are up across the country as OPOs build effective practices.
Using registries to improve outcomes and transplant management
UNOS builds and hosts registries enabling OPOs and transplant centers to address issues such as treatment, payment, quality improvement, benchmarking and clinical research.
Preserving candidate wait time during temporary inactivation due to COVID-19
Altering organ acceptance criteria protects candidates at risk of COVID-19 from losing accrued wait time.
